.png)
Academic Technology Transfer:
Its Origins and Global Impact
"Technology transfer supports all the pillars of the new global economy: innovation, technology, entrepreneurship and knowledge." This quote comes from the Association of University Technology Managers Foundation website, which is dedicated to supporting the critical work of creating university and industry partnerships to advance economic development and foster the technology transfer sector for the benefit of the global marketplace. In a world where technology drives all sectors, creating sustainable partnerships between researchers and innovators is critical.
While you may not have heard of the term technology transfer in the past, you have seen the end results impacting the everyday world we live in. Over 200 vaccines and drugs are the result of universities sharing critical research with business partners to further develop and commercialize research. From firefighting drones to artificial lungs, there are a wide range of amazing products and discoveries we have to thank technology transfer for.
Attendees of the Global Business Summit will come away with a better understanding of what technology transfer is, how it is driving global innovation, and the power it has to transform the world as we know it. In addition, you will have the opportunity to network with practitioners in the field to build connections and deepen understanding. Dr. Ashley Stevens, a leading voice in the field of Technology Transfer will provide critical insights into this important field, followed by an engaging discussion with local experts to further expand on the conversation.
Join us at Southern New Hampshire University on December 1st to gain a better understanding of this field that has created over 4 million jobs and more than $860 billion of GDP growth since 1996.
Event Schedule
5:00 pm - Pre-Event Reception Doors Open
6:00 pm - Event Begins
7:30 pm - Post Event Dinner for Patrons and Sponsors
SPONSORS
%204833-1101-6418%20v.1.png)
Patrons
Stephen Barndollar
Anna Berry
Robert Blair & Patricia Murphy
Peter Bowman & Helen Taft
Howard & Joan Brodsky
William Dunlap
Davis and Suzanna Farmer
Julie Gaye
Carolyn & Philip Hollman
Tom Horgan
Kevin Khan
Kimberly Peaslee, PhD.
Carolyn Richmond
Jack & Carol Resch
Diane Schaefer
David & Missie Schroeder
Anne Smith
Andy Supplee
Amb. Dick Swett
Virginia & Joe Szymanowski
Partners
About the Speaker
Dr. Ashley Stevens has worked in the entrepreneurial world since 1982, when he joined one of the first generation biotechnology companies, BioTechnica International, Inc. in Cambridge, MA. He subsequently co-founded two biotechnology companies: Genmap, Inc., the first company founded to work on the human genome, out of which emerged Myriad Genetics, Inc. and Kytogenics, Inc. a company that developed novel medical products based on modified chitosans. All three of these companies took academic technologies on their first steps into the marketplace and in 1991, he moved one step up the value chain and entered the then fledgling world of technology transfer. From 1991 to 1995, he was Director of Technology Transfer at the Dana-Farber Cancer Center, a teaching affiliate of the Harvard Medical Center and one of the US’ Comprehensive Cancer Centers.
In 1995, he moved to Boston University, where, until 2007, he was Director of the Office of Technology Transfer in the Community Technology Fund (which became the Office of Technology Development in 2005) and subsequently was Executive Director, Technology Transfer until his retirement in July 2011. Under his leadership, some 55 new companies were spun out of BU. For ten years he held an adjunct appointment in BU’s Questrom School of Management, where he taught two graduate level courses on the commercialization of early stage technologies, “Bench-to-Bedside” and Technology Entrepreneurship and Commercialization.
Each summer he is a Guest Professor at Osaka University, Japan, where he teaches a technology commercialization course called G-TEC and he was previously an Adjunct Principal Investigator at the National University of Singapore (NUS) Suzhou Research Institute. Since retiring from Boston University, he has chaired the Patent Committee of the Forsyth Institute, a leading research institute focused on oral health.
He was President of AUTM (formerly the Association of University Technology Managers) in 2010 / 11 and received AUTM’s Bayh-Dole Award in 2007 (from the hands of Senator Bayh himself!) He is both a Certified Licensing Professional (“CLP”) and a Registered Technology Transfer Professional (“RTTP”).
About the Panel
Andrew Share is the managing partner of Nixon Peabody’s Manchester, New Hampshire, office. Andrew has extensive technology transactions experience, counseling companies with respect to a wide range of intellectual property and technology–related matters, including software, content and data licensing, SaaS, software development and implementation, reseller arrangements, business process outsourcing, data privacy, and IT security concerns.
Additionally, Andrew regularly counsels clients in the commercialization and leveraging of their intellectual property assets, and is experienced in drafting and negotiating related agreements involving the creation, acquisition, or sale of rights to intellectual property.
Marc Eichenberger is the Associate Vice President and Chief Business Development and Innovation Officer at the University of New Hampshire and the Managing Director of UNHInnovation. He brings a wealth of experience in bridging the corporate and university ecosystems, intellectual property (IP) commercialization and business development.
In his most recent role before joining UNH, Marc help launch venture creation company, Allied Minds. As second employee and serving as the company’s chief operating officer, over 10 years he helped grow this start-up from inception to a public company. Allied Minds commercializes IP from leading US universities, national labs and corporations. The company forms, funds and operates a portfolio of companies based on this IP with the objective of delivering attractive long-term returns to investors and stakeholders.
Marc’s experiences in innovation span both life sciences and technology and cut across all functional areas. In addition to leading the company’s operations, he personally closed a number of partnerships with companies around the globe.
Prior to helping found Allied Minds, Marc spent over a decade in management consulting mostly with AT Kearney. There he advised mid-size and Fortune 500 companies on a variety of strategy, operations and supply chain issues. His clients represented a spectrum of aerospace, high-technology, services and industrial companies.
Marc graduated with a Master of Business Administration from The Wharton School of Business, University of Pennsylvania and is a Chartered Financial Analyst (CFA).
Julie Lenzer is the Chief Innovation Officer at the Advanced Regenerative Manufacturing Institute (ARMI) where she is charged with building the ecosystem and resources for startups who are creating cell, tissue, and organ therapies as well as enabling technologies across the supply chain, including raw materials, manufacturing, and distribution.
Previously, she was the Chief Innovation Officer at the University of Maryland (UMD) where she oversaw various campus-wide ecosystem components such as the technology transfer office, the statewide Small Business Development Center, and the EDA-funded, I-Corps based Innovation Extension University Center. She was also the founding director for the Quantum Startup Foundry and on the investment committees for the Maryland Momentum and Discovery investment funds.
Prior to her political appointment, Julie was the Executive Director of the Maryland Center for Entrepreneurship (MCE), an initiative of the Howard County Economic Development Authority focused on igniting the entrepreneurial culture and bringing together the entrepreneurial ecosystem across the state. During her tenure, the MCE quadrupled its client base and saw the creation of new programs such as 3D Maryland, a leadership initiative connecting resources in additive manufacturing; the Conscious Venture Lab, an accelerator focused on Conscious Capitalism; and a technology transfer accelerator in partnership with Johns Hopkins Advanced Physics Lab and other leading research institutions. Ms. Lenzer was also the co-chair of Startup Maryland as well as co-founder and former CEO of the Path Forward Center for Innovation and Entrepreneurship, a nonprofit that helped women expand economic opportunity by starting and building growth-oriented businesses using technology transfer.
A sought-after keynote speaker on topics such as leadership, innovation, and entrepreneurship, Julie has delivered keynotes and workshops across 4 continents. Her op-ed, “Everyone can have a trophy, or how to make the most of NOT getting Amazon HQ2” was published in the USA Today and previously, had been quoted as an expert in media brands such as Entrepreneur, Inc., Fast Company and Forbes as well as the NY Times, Chicago Tribune, Baltimore Sun, The Guardian and the Boston Globe.
Julie was recognized through Washington Business Journal’s 25 Women Who Mean Business in 2019, as a 2014 Influential Marylander, 2013 Trailblazer in Technology, and as AT&T's Innovator of the Year in 2011. She received designation for Excellence in Leadership in 2017 by Prince George’s County, a SmartCEO's BRAVA award winner in 2014, and was the 2004 Athena winner. She was also named to Maryland's Top 100 Women 2005, 2008 and 2014 at which time she joined the Circle of Excellence for sustained service to the community.
